US Stock MarketDetailed Quotes

LIXT Lixte Biotechnology

Watchlist

2.3100
-0.0801-3.35%

Close Jul 22 16:00 ET

5.20MMarket Cap-1017P/E (TTM)

Lixte Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-16.49%3.41M

-21.48%4.2M

-22.19%5.11M

-62.34%2.91M

8.22%4.09M

10.98%5.35M

10.09%6.56M

13.79%7.74M

-Cash and cash equivalents

-16.49%3.41M

-21.48%4.2M

-22.19%5.11M

-62.34%2.91M

8.22%4.09M

10.98%5.35M

10.09%6.56M

13.79%7.74M

Prepaid assets

-6.15%174.94K

-49.36%105.13K

-56.67%101.25K

-46.39%132.67K

-32.73%186.41K

-19.93%207.59K

-25.66%233.67K

-38.03%247.47K

Other current assets

----

16.21%27.84K

22.19%49.56K

8.05%56.1K

----

-25.65%23.96K

-9.60%40.56K

Total current assets

-17.12%3.59M

-22.52%4.31M

-23.24%5.23M

-61.43%3.1M

5.46%4.33M

9.18%5.56M

8.12%6.82M

10.79%8.02M

Non current assets

Total non current assets

--0

Total assets

-17.12%3.59M

-22.52%4.31M

-23.24%5.23M

-61.43%3.1M

5.18%4.33M

9.18%5.56M

7.67%6.82M

10.79%8.02M

Liabilities

Current liabilities

Payables

----

-32.06%156.76K

----

--230.73K

----

-accounts payable

----

-34.42%120.51K

----

--183.75K

----

-Due to related parties current

----

-22.84%36.25K

----

--46.98K

----

Current deferred liabilities

720.11%216.15K

-4.80%157.1K

-10.27%90.57K

-77.28%36.09K

-90.42%26.36K

114.42%165.02K

278.26%100.93K

-25.74%158.83K

Current liabilities

85.14%462.84K

-20.69%313.86K

-23.66%311.74K

-24.26%402.61K

-61.22%249.99K

30.64%395.76K

57.84%408.33K

41.24%531.54K

Non current liabilities

Total non current liabilities

--0

Total liabilities

85.14%462.84K

-20.69%313.86K

-23.66%311.74K

-24.26%402.61K

-61.22%249.99K

30.64%395.76K

57.84%408.33K

41.24%531.54K

Shareholders'equity

Share capital

-0.04%3.5M

0.00%3.5M

-0.04%3.5M

0.01%3.5M

-0.03%3.5M

0.01%3.5M

-common stock

-86.49%225

35.54%225

-86.48%225

-90.02%166

21.18%1.67K

-87.92%166

21.11%1.66K

21.82%1.66K

-Preferred stock

0.00%3.5M

Retained earnings

-10.48%-49.45M

-11.72%-48.48M

-13.61%-47.45M

-15.25%-46.43M

-15.55%-44.76M

-17.02%-43.39M

-19.14%-41.76M

-19.14%-40.29M

Paid-in capital

8.24%49.08M

8.69%48.98M

9.40%48.87M

3.04%45.62M

17.13%45.34M

17.43%45.06M

18.73%44.67M

19.09%44.28M

Total stockholders'equity

-23.39%3.13M

-22.66%3.99M

-23.21%4.92M

-64.06%2.69M

17.50%4.08M

7.83%5.17M

5.54%6.41M

9.12%7.49M

Total equity

-23.39%3.13M

-22.66%3.99M

-23.21%4.92M

-64.06%2.69M

17.50%4.08M

7.83%5.17M

5.54%6.41M

9.12%7.49M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-16.49%3.41M	-21.48%4.2M	-21.48%4.2M	-22.19%5.11M	-62.34%2.91M	8.22%4.09M	10.98%5.35M	10.98%5.35M	10.09%6.56M	13.79%7.74M
-Cash and cash equivalents	-16.49%3.41M	-21.48%4.2M	-21.48%4.2M	-22.19%5.11M	-62.34%2.91M	8.22%4.09M	10.98%5.35M	10.98%5.35M	10.09%6.56M	13.79%7.74M
Prepaid assets	-6.15%174.94K	-49.36%105.13K	-49.36%105.13K	-56.67%101.25K	-46.39%132.67K	-32.73%186.41K	-19.93%207.59K	-19.93%207.59K	-25.66%233.67K	-38.03%247.47K
Other current assets	----	----	----	16.21%27.84K	22.19%49.56K	8.05%56.1K	----	----	-25.65%23.96K	-9.60%40.56K
Total current assets	-17.12%3.59M	-22.52%4.31M	-22.52%4.31M	-23.24%5.23M	-61.43%3.1M	5.46%4.33M	9.18%5.56M	9.18%5.56M	8.12%6.82M	10.79%8.02M
Non current assets
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-17.12%3.59M	-22.52%4.31M	-22.52%4.31M	-23.24%5.23M	-61.43%3.1M	5.18%4.33M	9.18%5.56M	9.18%5.56M	7.67%6.82M	10.79%8.02M
Liabilities
Current liabilities
Payables	----	-32.06%156.76K	-32.06%156.76K	----	----	----	--230.73K	--230.73K	----	----
-accounts payable	----	-34.42%120.51K	-34.42%120.51K	----	----	----	--183.75K	--183.75K	----	----
-Due to related parties current	----	-22.84%36.25K	-22.84%36.25K	----	----	----	--46.98K	--46.98K	----	----
Current deferred liabilities	720.11%216.15K	-4.80%157.1K	-4.80%157.1K	-10.27%90.57K	-77.28%36.09K	-90.42%26.36K	114.42%165.02K	114.42%165.02K	278.26%100.93K	-25.74%158.83K
Current liabilities	85.14%462.84K	-20.69%313.86K	-20.69%313.86K	-23.66%311.74K	-24.26%402.61K	-61.22%249.99K	30.64%395.76K	30.64%395.76K	57.84%408.33K	41.24%531.54K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	85.14%462.84K	-20.69%313.86K	-20.69%313.86K	-23.66%311.74K	-24.26%402.61K	-61.22%249.99K	30.64%395.76K	30.64%395.76K	57.84%408.33K	41.24%531.54K
Shareholders'equity
Share capital	-0.04%3.5M	0.00%3.5M	0.00%3.5M	-0.04%3.5M	-0.04%3.5M	0.01%3.5M	-0.03%3.5M	-0.03%3.5M	0.01%3.5M	0.01%3.5M
-common stock	-86.49%225	35.54%225	35.54%225	-86.48%225	-90.02%166	21.18%1.67K	-87.92%166	-87.92%166	21.11%1.66K	21.82%1.66K
-Preferred stock	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M	0.00%3.5M
Retained earnings	-10.48%-49.45M	-11.72%-48.48M	-11.72%-48.48M	-13.61%-47.45M	-15.25%-46.43M	-15.55%-44.76M	-17.02%-43.39M	-17.02%-43.39M	-19.14%-41.76M	-19.14%-40.29M
Paid-in capital	8.24%49.08M	8.69%48.98M	8.69%48.98M	9.40%48.87M	3.04%45.62M	17.13%45.34M	17.43%45.06M	17.43%45.06M	18.73%44.67M	19.09%44.28M
Total stockholders'equity	-23.39%3.13M	-22.66%3.99M	-22.66%3.99M	-23.21%4.92M	-64.06%2.69M	17.50%4.08M	7.83%5.17M	7.83%5.17M	5.54%6.41M	9.12%7.49M
Total equity	-23.39%3.13M	-22.66%3.99M	-22.66%3.99M	-23.21%4.92M	-64.06%2.69M	17.50%4.08M	7.83%5.17M	7.83%5.17M	5.54%6.41M	9.12%7.49M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall